Get started
YICHANG HEC CHANGJIANG PHARMACTL COYICHANG HEC CHANGJIANG PHARMACTL COYICHANG HEC CHANGJIANG PHARMACTL CO

YICHANG HEC CHANGJIANG PHARMACTL CO

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

1558 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and others. Its products include Benzbromarone, Telmisartan, Amlodipine Besylate, and Cetirizine Hydrochloride. The company was founded on August 8, 2001 and is headquartered in Yichang, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
1558 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company